Finance

Lists
600380:SHA
Joincare Pharmaceutical Group Ind. Co.
CNÂ¥10.05
+1.01%
(+0.10) 1D
Oct 30, 3:00:02 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600380...
Open
CNÂ¥9.95
High
CNÂ¥10.12
Low
CNÂ¥9.87
Mkt. cap
18.39B
Avg. vol.
18.38M
Volume
17.52M
Dividend
8.16%
Quarterly dividend
CNÂ¥0.21
Ex-dividend date
Oct 20, 2026
P/E ratio
16.26
52-wk high
CNÂ¥12.85
52-wk low
CNÂ¥9.00
EPS
CNÂ¥0.62
Shares outstanding
1.94B
No. of employees
14K
Open
CNÂ¥9.95
High
CNÂ¥10.12
Low
CNÂ¥9.87
Mkt. cap
18.39B
Avg. vol.
18.38M
Volume
17.52M
Dividend
8.16%
Quarterly dividend
CNÂ¥0.21
Ex-dividend date
Oct 20, 2026
P/E ratio
16.26
52-wk high
CNÂ¥12.85
52-wk low
CNÂ¥9.00
EPS
CNÂ¥0.62
Shares outstanding
1.94B
No. of employees
14K
News stories
From web sources and news partners
About Joincare Pharmaceutical Group Ind. Co.
CEO-
Employees13.6K
FoundedDec 18, 1992
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
3.74B
3.72B
2.86B
3.09B
Cost of goods sold
1.51B
1.37B
1.35B
1.37B
Cost of revenue
1.51B
1.37B
1.35B
1.37B
Research and development expenses
342.00M
233.70M
277.02M
281.24M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.32B
1.10B
727.15M
932.32M
Operating expense
1.80B
1.37B
1.03B
1.19B
Total operating expenses
3.31B
2.74B
2.38B
2.56B
Operating income
426.27M
979.97M
477.33M
528.28M
Other non operating income
45.09M
-35.19M
32.02M
49.29M
EBT including unusual items
513.57M
1.04B
564.16M
592.64M
EBT excluding unusual items
496.11M
1.04B
537.69M
665.90M
Income tax expense
93.11M
153.39M
81.41M
81.01M
Effective tax rate
18.13%
14.79%
14.43%
13.67%
Other operating expenses
148.93M
39.82M
31.28M
-25.16M
Net income
244.33M
414.97M
232.68M
238.86M
Net profit margin
6.54%
11.15%
8.13%
7.74%
Earnings per share
-
-
-
-
Interest and investment income
111.66M
113.93M
112.08M
32.88M
Interest expense
-20.23M
-15.50M
-17.38M
-10.91M
Net interest expenses
91.43M
98.43M
94.69M
21.97M
Depreciation and amortization charges
-
-
-
-
EBITDA
620.96M
1.17B
679.37M
722.97M
Gain or loss from assets sale
4.07M
-
6.99M
-6.99M
Upcoming events
AI content may include mistakes. Learn more
Google apps